MNMD

Mind Medicine Inc

Aug 29 • 04:00PM ET

8.88

Dollar change -0.90
Percentage change -9.20	%

Healthcare • Biotechnology • USA • NASD

Peers: ATAI CYBN CMPS GHRS RLAY RLMD PLRX VTGN FBRX

| Held by: IWM VXF IWN VTWO SCHA XPH IWO IHE VHT IWC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.46	Insider Own	4.01%	Shs Outstand	75.80M	Perf Week	-12.86%
Market Cap	675.66M	Forward P/E	-	EPS next Y	-1.85	Insider Trans	-2.64%	Shs Float	72.52M	Perf Month	-2.31%
Enterprise Value	533.86M	PEG	-	EPS next Q	-0.50	Inst Own	54.47%	Short Float	14.19%	Perf Quarter	22.31%
Income	-114.52M	P/S	-	EPS this Y	-14.70%	Inst Trans	1.80%	Short Ratio	8.49	Perf Half Y	32.14%
Sales	0.00M	P/B	3.63	EPS next Y	-4.79%	ROA	-42.95%	Short Interest	10.29M	Perf YTD	27.59%
Book/sh	2.45	P/C	3.69	EPS next 5Y	1.12%	ROE	-59.11%	52W High	11.02 -19.42%	Perf Year	42.54%
Cash/sh	2.40	P/FCF	-	EPS past 3/5Y	23.15% 12.11%	ROIC	-50.54%	52W Low	4.70 88.94%	Perf 3Y	-32.02%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	7.76% 6.42%	Perf 5Y	71.84%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	39.66%	Oper. Margin	-	ATR (14)	0.59	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	4.98	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	42.07	Recom	1.09
Dividend Gr. 3/5Y	- -	Current Ratio	4.98	EPS Q/Q	-515.23%	SMA20	-8.98%	Beta	2.97	Target Price	25.00
Payout	-	Debt/Eq	0.22	Sales Q/Q	-	SMA50	1.10%	Rel Volume	1.69	Prev Close	9.78
Employees	74	LT Debt/Eq	0.22	Earnings	Jul 31 AMC	SMA200	19.06%	Avg Volume	1.21M	Price	8.88
IPO	Nov 15, 2016	Option/Short	Yes / Yes	EPS/Sales Surpr.	-31.58% -	Trades		Volume	2,051,631	Change	-9.20%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-04-25	Resumed	Oppenheimer	Outperform	$25
Jan-28-25	Initiated	Evercore ISI	Outperform	$23
Dec-20-24	Initiated	Chardan Capital Markets	Buy	$20
Oct-14-24	Resumed	Leerink Partners	Outperform	$20
Jul-24-24	Initiated	ROTH MKM	Buy	$36
May-29-24	Initiated	Robert W. Baird	Outperform	$27
Apr-15-24	Initiated	Leerink Partners	Outperform	$20
Dec-05-23	Initiated	Canaccord Genuity	Buy	$9
Dec-09-22	Resumed	ROTH Capital	Buy	$25
Nov-16-22	Initiated	RBC Capital Mkts	Outperform	$5
Aug-26-22	Initiated	Oppenheimer	Outperform	$3.50
Aug-10-22	Initiated	Cantor Fitzgerald	Overweight	$3
May-04-22	Initiated	ROTH Capital	Buy	$7
Jun-28-21	Initiated	Maxim Group	Buy	$6

Show Previous Ratings

Aug-28-25 07:00AM	MindMed to Participate in September Investor Conferences (Business Wire)
Aug-12-25 03:43AM	If You'd Invested $1,000 in Mind Medicine (MNMD) Stock 5 Years Ago, Here's How Much You'd Have Today (Motley Fool)
Aug-11-25 04:01PM	MindMed Announces New Employee Inducement Grants (Business Wire)
Aug-07-25 05:25AM	1 Reason to Buy MindMed (MNMD) (Motley Fool)
Aug-01-25 03:36AM	Mind Medicine Inc (MNMD) Q2 2025 Earnings Call Highlights: Strategic Advances and Financial ... (GuruFocus.com) -7.15%
04:01PM	Loading…
Jul-31-25 04:01PM	MindMed Reports Q2 2025 Financial Results and Business Updates (Business Wire)
Jul-25-25 09:40AM	Is Anixa Biosciences (ANIX) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jul-24-25 07:00AM	MindMed to Report Second Quarter 2025 Financial Results on July 31, 2025 (Business Wire)
Jul-22-25 12:00PM	All You Need to Know About Mind Medicine MindMed (MNMD) Rating Upgrade to Buy (Zacks)
Jul-14-25 04:01PM	MindMed Announces New Employee Inducement Grants (Business Wire)
Jun-27-25 11:50AM	Psychedelic: Compass Pathways achieves primary endpoint in COMP360 trial (TipRanks)
Jun-19-25 10:10AM	Trump Trade: President said to weigh possible U.S. strike against Iran (TipRanks)
09:26AM	Psychedelic advocates hopeful Trump administration will support space, STAT says (TipRanks)
12:01AM	This Illegal Psychedelic Is Hailed as a Revolutionary Breakthrough (WSJ)
Jun-09-25 04:01PM	MindMed Announces New Employee Inducement Grants (Business Wire)
07:02AM	Loading…
Jun-04-25 07:02AM	Why Mind Medicine Gave Investors a Powerful Buzz in May (Motley Fool)
Jun-02-25 09:55AM	Wall Street Analysts Believe Mind Medicine MindMed (MNMD) Could Rally 237.47%: Here's is How to Trade (Zacks)
May-28-25 07:00AM	MindMed to Participate in June Investor Conferences (Business Wire)
May-27-25 07:00AM	MindMed Strengthens Executive Team with Appointment of Brandi Roberts, CPA, as Chief Financial Officer (Business Wire)
May-21-25 11:18AM	Mind Medicine (MindMed) Inc. (MNMD): Analysts See 285% Upside Potential (Insider Monkey) -8.68%
May-20-25 05:33PM	Why Mind Medicine Stock Vaulted More Than 8% Higher Today (Motley Fool) +8.42%
May-19-25 04:01PM	MindMed Announces New Employee Inducement Grants (Business Wire) +6.21%
May-16-25 04:17PM	Was Jim Cramer Right About Mind Medicine (MNMD) Stock? (Insider Monkey)
May-13-25 09:55AM	Does Mind Medicine MindMed (MNMD) Have the Potential to Rally 279.84% as Wall Street Analysts Expect? (Zacks)
07:00AM	MindMed to Present at the 2025 RBC Capital Markets Global Healthcare Conference (Business Wire)
May-09-25 11:11AM	Psychedelic: Compass, GH Research, MindMed report quarterly earnings (TipRanks)
May-08-25 07:00AM	MindMed Reports First Quarter 2025 Financial Results and Recent Business Updates (Business Wire)
May-07-25 12:33PM	Mind Medicine Q1 2025 Earnings Preview (Seeking Alpha)
Apr-24-25 07:00AM	MindMed to Report First Quarter 2025 Financial Results on May 8, 2025 (Business Wire) +5.24%
Apr-23-25 07:42PM	Mind Medicine: Strong Data, But Psychedelic Stigma Still Clouds Investor Confidence (Seeking Alpha) +5.34%
04:01PM	Loading…
Apr-21-25 04:01PM	MindMed Announces New Employee Inducement Grants (Business Wire)
Apr-20-25 10:33PM	Mind Medicine: Initiating Hold Rating Due To Regulatory Challenges (Seeking Alpha)
Apr-15-25 07:00AM	MindMed Announces First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder (MDD) (Business Wire)
Mar-24-25 04:01PM	MindMed Announces New Employee Inducement Grants (Business Wire)
Mar-22-25 10:30AM	Psychedelic: Exclusive talk with biotech company Clearmind Medicine (TipRanks)
Mar-21-25 11:50AM	Psychedelic: atai Life Sciences, NRx report quarterly results (TipRanks)
Mar-17-25 07:00AM	MindMed Appoints Matt Wiley as Chief Commercial Officer (Business Wire)
Mar-14-25 11:40AM	Psychedelic: atai reports dosing of first patient in Phase 2 VLS-01 trial (TipRanks)
Mar-06-25 07:00AM	MindMed Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Updates (Business Wire)
Mar-04-25 07:00AM	MindMed to Present at Leerink's Global Healthcare Conference 2025 (Business Wire)
Feb-28-25 11:30AM	Psychedelic: GH Research, Compass Pathways report earnings results (TipRanks)
Feb-20-25 07:00AM	MindMed to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025 (Business Wire)
Feb-13-25 04:14PM	It's Official: The Senate Will Let Robert F. Kennedy Jr. 'Go Wild' On Health Care (Investor's Business Daily) +14.34%
Feb-12-25 01:25PM	RFK Jr. Confirmation Looms. How Kennedy Could 'Go Wild' On Health Care. (Investor's Business Daily)
Feb-04-25 07:00AM	MindMed to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference (Business Wire) +10.85%
Jan-31-25 07:20AM	Mind Medicine doses first patient in Panorama study (TipRanks)
Jan-30-25 07:00AM	MindMed Announces First Patient Dosed in Panorama, the Second Pivotal Phase 3 Study of MM120 in Generalized Anxiety Disorder (Business Wire)
Jan-20-25 10:48AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Dec-19-24 07:00AM	MindMed to Be Added to the Nasdaq Biotechnology Index (Business Wire)
Dec-16-24 07:00AM	MindMed Announces First Patient Dosed in Phase 3 Voyage Study of MM120 in Generalized Anxiety Disorder (GAD) (Business Wire)
Dec-11-24 07:00AM	MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress (Business Wire)
Dec-05-24 07:00AM	MindMed Awarded Innovation Passport Designation by the United Kingdom (UK) Innovative Licensing and Access Pathway (ILAP) Steering Group for MM120 Orally Disintegrating Tablet (ODT) for Generalized Anxiety Disorder (GAD) (Business Wire)
Dec-03-24 07:00AM	MindMed Appoints Javier Muniz, M.D., as Vice President of Research and Development Strategy (Business Wire) -7.99%
Dec-02-24 07:00AM	MindMed Announces New Employee Inducement Grants (Business Wire)
Nov-18-24 07:00AM	MindMed Appoints Gregg Pratt, Ph.D. as Chief Regulatory and Quality Assurance Officer (Business Wire) -11.86%
Nov-13-24 07:00AM	MindMed to Participate in Upcoming Investor Conferences (Business Wire)
Nov-07-24 04:01PM	MindMed Reports Third Quarter 2024 Financial Results and Business Updates (Business Wire) +11.41% +12.90%
Oct-24-24 07:00AM	MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2024 Financial Results and Provide Business Update (Business Wire)
Oct-12-24 06:05PM	Mind Medicine assumed with an Outperform at Leerink (TipRanks)
Sep-09-24 04:01PM	MindMed Announces New Employee Inducement Grants (Business Wire)
Sep-04-24 07:00AM	MindMed to Participate in September Investor Conferences (Business Wire) +5.86%
Aug-13-24 07:00AM	MindMed Reports Second Quarter 2024 Financial Results and Business Updates (Business Wire)
Aug-12-24 09:02PM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Aug-09-24 08:44AM	Mind Medicine (MindMed) Inc. Announces Pricing of Public Offering (Business Wire) -10.03%
06:00AM	Mind Medicine (MindMed) Inc. Announces Proposed Public Offering (Business Wire)
Aug-06-24 04:01PM	MindMed to Present at Canaccord Genuitys 44th Annual Growth Conference (Business Wire)
07:00AM	MindMed to Host Conference Call and Webcast to Discuss Second Quarter 2024 Financial Results and Provide Business Update (Business Wire)
Jul-29-24 07:00AM	MindMed Appoints Stephanie Fagan as Chief Corporate Affairs Officer (Business Wire)
Jul-17-24 07:00AM	MindMed Announces Issuance of New Patent for MM120 Orally Disintegrating Tablet (ODT) (Business Wire)
Jul-06-24 07:21AM	3 Psychedelic Stocks to Ride to the Moon and Beyond (InvestorPlace)
Jul-04-24 02:13PM	FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals (InvestorPlace)
Jun-28-24 07:00AM	MindMed to be Included in Russell 2000 and Russell 3000 Indexes (Business Wire)
Jun-21-24 07:00AM	MindMed to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference (Business Wire)
Jun-20-24 07:00AM	MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD) (Business Wire)
Jun-18-24 12:31PM	Wall Street Favorites: 3 Penny Stocks With Strong Buy Ratings for June 2024 (InvestorPlace)
Jun-14-24 09:40AM	Is Mind Medicine MindMed (MNMD) Outperforming Other Medical Stocks This Year? (Zacks)
Jun-05-24 11:42AM	Psychedelic Drug Stocks Plummet On FDA Advisers' Doubts About Ecstasy Candidate (The Wall Street Journal) -10.06%
May-29-24 09:40AM	Are Medical Stocks Lagging Mind Medicine MindMed (MNMD) This Year? (Zacks) +6.64%
May-28-24 07:00AM	MindMed to Participate in June Conferences (Business Wire)
May-23-24 03:41PM	The Time Traveler's Portfolio: 3 Stocks to Buy Now for Massive Returns by 2034 (InvestorPlace) -5.36%
May-18-24 09:32AM	Jim Cramer's Latest Stock Picks in May 2024 (Insider Monkey)
May-10-24 11:00AM	Top Russell 2000 Picks: 3 Small-Cap Stocks to Scoop Up This May (InvestorPlace)
May-09-24 04:01PM	MindMed to Participate at May Investor Conferences (Business Wire) -5.10%
08:00AM	New Studies Presented at the International Society for Health Economics and Outcomes Research Meeting (ISPOR 24) Show Growing Burden and Impact of Generalized Anxiety Disorder (GAD) in the US (Business Wire)
06:49AM	Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine (InvestorPlace)
May-08-24 09:00PM	MNMD Stock Earnings: Mind Medicine Misses EPS for Q1 2024 (InvestorPlace)
04:01PM	MindMed Reports First Quarter 2024 Financial Results and Business Updates (Business Wire)
May-04-24 08:00AM	MindMed Presents Phase 2b Study of MM120 for Generalized Anxiety Disorder (GAD) at American Psychiatric Association (APA) Annual Meeting in New York (Business Wire)
May-02-24 07:00AM	MindMed to Host Conference Call and Webcast to Discuss First Quarter 2024 Financial Results and Provide Business Update (Business Wire)
Apr-25-24 07:00AM	MindMed to Present at Upcoming May Medical Conferences (Business Wire)
Apr-08-24 06:59AM	MindMed (MNMD) Stock Rises 154% in 3 Months: Here's Why (Zacks)
Apr-02-24 07:00AM	MindMed to Present at Upcoming April Medical Conferences (Business Wire)
Apr-01-24 05:00PM	MindMed Announces Voluntary Delisting from Cboe Canada (Business Wire)
Mar-19-24 08:00AM	The Next Great Biotech Boom Has Arrived (PR Newswire)
Mar-11-24 07:00AM	MindMed to Participate in the Leerink Partners 2024 Global Biopharma Conference (Business Wire) -14.02%
Mar-10-24 11:10AM	Weekly Roundup on the Cannabis Sector & Psychedelic Sector (Market Exclusive)
Mar-08-24 10:46AM	MindMed's (MNMD) Anxiety Drug Gets FDA Breakthrough Therapy Tag (Zacks) +7.78%
07:00AM	Numinus Wellness Congratulates MindMed on Positive Results from Phase 2B Clinical Trials of MM120 for Generalized Anxiety Disorder (PR Newswire)
Mar-07-24 07:13AM	Mind Medicine (MindMed) Inc. Announces Pricing of Underwritten Offering of Common Shares and Concurrent Private Placement (Business Wire) +51.52%
06:00AM	MindMed Receives FDA Breakthrough Therapy Designation and Announces Positive 12-Week Durability Data From Phase 2B Study of MM120 for Generalized Anxiety Disorder (Business Wire)

Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sullivan Mark	Chief Legal Officer	Jun 25 '25	Sale	6.80	11,491	78,139	305,130	Jun 26 04:30 PM
Karlin Daniel	Chief Medical Officer	Jun 25 '25	Sale	6.80	7,848	53,366	438,329	Jun 26 04:30 PM
Barrow Robert	Chief Executive Officer	Jun 25 '25	Sale	6.80	26,491	180,139	830,065	Jun 26 04:30 PM
DANIEL ROLLINGS KARLIN	Officer	Jun 25 '25	Proposed Sale	6.80	7,848	53,388		Jun 25 04:09 PM
MARK SULLIVAN	Officer	Jun 25 '25	Proposed Sale	6.80	11,491	78,170		Jun 25 04:07 PM
ROBERT B BARROW	Officer	Jun 25 '25	Proposed Sale	6.80	26,491	180,210		Jun 25 04:05 PM
Barrow Robert	Chief Executive Officer	Mar 25 '25	Sale	6.74	21,208	142,942	856,556	Mar 26 05:00 PM
Karlin Daniel	Chief Medical Officer	Mar 25 '25	Sale	6.74	6,836	46,075	446,177	Mar 26 05:00 PM
Sullivan Mark	Chief Legal Officer	Mar 25 '25	Sale	6.74	6,576	44,322	316,621	Mar 26 05:00 PM
Liao Carrie	Chief Accounting Officer	Mar 25 '25	Sale	6.74	2,347	15,819	144,923	Mar 26 05:00 PM
MARK SULLIVAN	Officer	Mar 25 '25	Proposed Sale	6.74	6,576	44,304		Mar 25 04:11 PM
CARRIE LIAO	Officer	Mar 25 '25	Proposed Sale	6.74	2,347	15,812		Mar 25 04:09 PM
ROBERT B BARROW	Officer	Mar 25 '25	Proposed Sale	6.74	21,208	142,883		Mar 25 04:06 PM
DANIEL ROLLINGS KARLIN	Officer	Mar 25 '25	Proposed Sale	6.74	6,836	46,056		Mar 25 04:03 PM
Barrow Robert	Chief Executive Officer	Dec 26 '24	Sale	7.43	19,106	141,958	526,666	Dec 27 04:31 PM
Liao Carrie	Chief Accounting Officer	Dec 26 '24	Sale	7.43	2,273	16,888	97,270	Dec 27 04:31 PM
Karlin Dan	Chief Medical Officer	Dec 26 '24	Sale	7.43	6,643	49,357	338,013	Dec 27 04:30 PM
Sullivan Mark	Chief Legal Officer	Dec 26 '24	Sale	7.43	4,519	33,576	173,197	Dec 27 04:30 PM
ROBERT B BARROW	Officer	Dec 26 '24	Proposed Sale	7.43	19,106	141,979		Dec 26 04:39 PM
MARK SULLIVAN	Officer	Dec 26 '24	Proposed Sale	7.43	4,519	33,581		Dec 26 04:31 PM
DAN ROLLINGS KARLIN	Officer	Dec 26 '24	Proposed Sale	7.43	6,643	49,365		Dec 26 04:30 PM
CARRIE LIAO	Officer	Dec 26 '24	Proposed Sale	7.43	2,273	16,891		Dec 26 04:28 PM
GRYSKA DAVID W	Director	Dec 05 '24	Buy	7.17	2,500	17,925	19,851	Dec 05 04:30 PM
Sullivan, Mark	Officer	Sep 25 '24	Proposed Sale	5.98	4,430	26,487		Sep 25 08:31 PM
Liao Carrie	Chief Accounting Officer	Sep 25 '24	Sale	5.98	2,352	14,065	99,543	Sep 25 08:30 PM
Barrow Robert	Chief Executive Officer	Sep 25 '24	Sale	5.98	19,771	118,231	545,772	Sep 25 08:29 PM
Karlin, Dan	Officer	Sep 25 '24	Proposed Sale	5.98	6,871	41,081		Sep 25 08:29 PM
Karlin Dan	Chief Medical Officer	Sep 25 '24	Sale	5.98	6,871	41,089	344,656	Sep 25 08:29 PM
Sullivan Mark	Chief Legal Officer	Sep 25 '24	Sale	5.98	4,430	26,491	177,716	Sep 25 08:28 PM
Barrow, Robert	Officer, Director	Sep 25 '24	Proposed Sale	5.98	19,771	118,210		Sep 25 08:27 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MNMD

Mind Medicine Inc

Upgrade your FINVIZ experience